Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial

IMPORTANCE: After the occurrence of nonfatal cardiovascular events, recurrent events are highly likely. Most cardiovascular outcomes trials analyze first events only; extending analyses to first and recurrent (total) events can provide clinically meaningful information. OBJECTIVE: To investigate whe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Cardiol
Autori principali: Verma, Subodh, Bain, Stephen C., Buse, John B., Idorn, Thomas, Rasmussen, Søren, Ørsted, David D., Nauck, Michael A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2019
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6865601/
https://ncbi.nlm.nih.gov/pubmed/31721979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2019.3080
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi